atbtherapeutics
Developer of antibody-based targeted therapy from plant cells designed to provide novel therapeutic treatment for patients with hard-to-treat cancer. The company develops antibodies with a new class o...
Valuation
$0
Share Price
N/A
Total Raised
$66.1M
Last Round
N/A